Edition:
United States

People: Celgene Corp (CELG.O)

CELG.O on Nasdaq

143.89USD
22 Sep 2017
Change (% chg)

$0.11 (+0.08%)
Prev Close
$143.78
Open
$143.31
Day's High
$144.19
Day's Low
$141.75
Volume
3,549,466
Avg. Vol
3,783,014
52-wk High
$144.59
52-wk Low
$96.93

Hugin, Robert 

Mr. Robert J. Hugin serves as Executive Chairman of the Board of the Company. Prior thereto he was Chairman of our Board of Directors since June 2011, Chief Executive Officer since June 16, 2010, President from May 1, 2006 to July 31, 2014, Chief Operating Officer from May 1, 2006 to June 16, 2010, and Senior Vice President and Chief Financial Officer from June 1999 to May 1, 2006. Mr. Hugin has served as one of our Directors since December 2001. Previously, Mr. Hugin had been a Managing Director at J.P. Morgan & Co. Inc., which he joined in 1985. Mr. Hugin received an AB degree from Princeton University in 1976 and an MBA from the University of Virginia in 1985 and served as a United States Marine Corps infantry officer during the intervening period. Mr. Hugin is also a Director of The Medicines Company, Danaher Corporation (and a member of each company’s Compensation Committee), Atlantic Health System, Inc., a non-profit health care system, and Family Promise, a national non-profit network assisting homeless families.Mr. Hugin brings to his role as a director his extensive executive and leadership experience at Celgene and his previous business experience, as well as his leadership roles on the boards of a public company and a non-profit health care company. In particular, his experience as our Chief Executive Officer, President, Chief Operating Officer and Chief Financial Officer and his current role as our Executive Chairman enable him to provide leadership and unique insight on complex business and financial matters and guidance with respect to the strategic goals and operating framework of a high growth company such as ours. Additionally, Mr. Hugin served as Chairman of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) from April 2013 until April 2014, is a past Chairman of the HealthCare Institute of New Jersey and is a member of the Board of Trustees of Princeton University. In these roles, he has gained valuable knowledge of regulatory, legal and legislative iss

Basic Compensation

Total Annual Compensation, USD 7,794,050
Restricted Stock Awards, USD 4,257,760
Long-Term Incentive Plans, USD --
All Other, USD 4,474,420
Fiscal Year Total, USD 16,526,200

Options Compensation

  Quantity Market Value
Exercisable 2,998,286 60,442,600.00
Unexercisable 11,667 --
Exercised 22,680 1,737,560.00
Name Fiscal Year Total

Robert Hugin

16,526,200

Scott Smith

6,463,800

Mark Alles

12,192,400

Peter Kellogg

8,137,270

Terrie Curran

--

Michael Pehl

--
As Of  30 Dec 2016